These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8217948)
1. [Establishment of a cisplatin-resistant human ovarian cancer cell line]. Sasa H; Hisano A; Ishii K; Hirata J; Kikuchi Y; Nagata I; Senoo A; Aida S; Tamai S; Sugita M Hum Cell; 1993 Jun; 6(2):106-13. PubMed ID: 8217948 [TBL] [Abstract][Full Text] [Related]
2. [Establishment and characterization of a CA125-producing human ovarian clear cell carcinoma cell line]. Sasa H; Ishii K; Hirata J; Kikuchi Y; Nagata I; Kawai T; Senoo A; Sugita M; Sugishita T; Tenjin Y Hum Cell; 1993 Dec; 6(4):279-86. PubMed ID: 8148309 [TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells. Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948 [TBL] [Abstract][Full Text] [Related]
4. [Establishment of a new human ovarian serous cystadenocarcinoma cell line (IM), and influence on cell proliferations by cisplatin with or without hyperthermia]. Iida T; Yoshida N; Kuramoto H; Shimoda T; Hamano M; Hata H; Yonamine K; Hayashi K Hum Cell; 1996 Dec; 9(4):345-52. PubMed ID: 9183668 [TBL] [Abstract][Full Text] [Related]
5. Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray. Sakamoto M; Kondo A; Kawasaki K; Goto T; Sakamoto H; Miyake K; Koyamatsu Y; Akiya T; Iwabuchi H; Muroya T; Ochiai K; Tanaka T; Kikuchi Y; Tenjin Y Hum Cell; 2001 Dec; 14(4):305-15. PubMed ID: 11925933 [TBL] [Abstract][Full Text] [Related]
6. [Cytokinetic effects of cisplatin on cisplatin-resistant ovarian cancer cell lines]. Sasa H; Kikuchi Y; Hisano A; Ishii K; Nagata I; Kawai T; Aida S; Sugita M; Sugishita T; Tenjin Y Hum Cell; 1992 Dec; 5(4):384-91. PubMed ID: 1304801 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a human ovarian carcinoma cell line: UCI 101. Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692 [TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a new human cell-line (AMOC-2) derived from a serous adenocarcinoma of ovary. Yabushita H; Ueno N; Sawaguchi K; Higuchi K; Noguchi M; Ishihara M Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):888-94. PubMed ID: 2794621 [TBL] [Abstract][Full Text] [Related]
9. [Establishment and characterization of a human chorionic gonadotropin (hCG) producing cell line (RTSG) from an ovarian epithelial cancer]. Udagawa Y; Nozawa S; Chin K; Sakayori M; Mikami M; Ohta K; Tsukazaki K; Kiguchi K; Iizuka R Hum Cell; 1990 Mar; 3(1):70-5. PubMed ID: 2083225 [TBL] [Abstract][Full Text] [Related]
10. [Establishment of a cisplatin-resistant human ovarian cancer cell line and the mechanism of resistance]. Kikuchi Y; Iwano I; Miyauchi M; Kita T; Kizawa I; Oomori K; Kato K Nihon Sanka Fujinka Gakkai Zasshi; 1988 Mar; 40(3):379-83. PubMed ID: 3361190 [TBL] [Abstract][Full Text] [Related]
11. [Experimental study on the mechanism of cisplatin resistance and its reversion in human ovarian cancer]. Liang Z; Bian D Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):75-8. PubMed ID: 8758797 [TBL] [Abstract][Full Text] [Related]
12. [Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611]. Huang JS Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):416-8. PubMed ID: 2634538 [TBL] [Abstract][Full Text] [Related]
13. [Identification and characterization of stem cells in an ovarian cancer cell line and examination their drug resistance]. Wei Z; Wang Y; Yu X; Zhang S Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):452-7. PubMed ID: 26311554 [TBL] [Abstract][Full Text] [Related]
14. Characterization of newly established cell line HUOA from a human ovarian serous cystadenocarcinoma. Ishiwata I; Ishiwata C; Kobayashi N; Ishikawa H Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):831-6. PubMed ID: 3598277 [TBL] [Abstract][Full Text] [Related]
15. [Biological properties of two newly established cell lines (RMUG-S, RMUG-L) from a human ovarian mucinous cystadenocarcinoma]. Sakayori M; Nozawa S; Udagawa Y; Chin K; Lee SG; Sakuma T; Iizuka R; Wada Y; Yoshida S; Takeda Y Hum Cell; 1990 Mar; 3(1):52-6. PubMed ID: 2083224 [TBL] [Abstract][Full Text] [Related]
16. Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning--with special reference to the stem cell of the tumor. Nozawa S; Tsukazaki K; Sakayori M; Jeng CH; Iizuka R Hum Cell; 1988 Dec; 1(4):426-35. PubMed ID: 3154025 [TBL] [Abstract][Full Text] [Related]
17. [The establishment of human ovarian carcinoma cell line HO-8910 and its characteristics]. Mou HZ; Xu SH; Zhang YY Zhonghua Fu Chan Ke Za Zhi; 1994 Mar; 29(3):162-4, 191. PubMed ID: 8082435 [TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers. Goto T; Takano M; Sakamoto M; Kondo A; Hirata J; Kita T; Tsuda H; Tenjin Y; Kikuchi Y Oncol Rep; 2006 May; 15(5):1265-71. PubMed ID: 16596196 [TBL] [Abstract][Full Text] [Related]
19. [Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray]. Konno R Hum Cell; 2001 Dec; 14(4):261-6. PubMed ID: 11925926 [TBL] [Abstract][Full Text] [Related]
20. Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation. Kikuchi Y; Kizawa I; Oomori K; Miyauchi M; Kita T; Sugita M; Tenjin Y; Kato K Cancer Res; 1987 Jan; 47(2):592-6. PubMed ID: 3791243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]